IDEXX Laboratories, Inc. (IDXX)
USD 410.69
(2.07%)
USD 410.69
(2.07%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.66 Billion USD | 8.72% |
| 2022 | 3.36 Billion USD | 4.73% |
| 2021 | 3.21 Billion USD | 18.79% |
| 2020 | 2.7 Billion USD | 12.45% |
| 2019 | 2.4 Billion USD | 8.75% |
| 2018 | 2.21 Billion USD | 12.4% |
| 2017 | 1.96 Billion USD | 10.91% |
| 2016 | 1.77 Billion USD | 10.83% |
| 2015 | 1.6 Billion USD | 7.81% |
| 2014 | 1.48 Billion USD | 7.9% |
| 2013 | 1.37 Billion USD | 6.47% |
| 2012 | 1.29 Billion USD | 6.13% |
| 2011 | 1.21 Billion USD | 10.45% |
| 2010 | 1.1 Billion USD | 6.96% |
| 2009 | 1.03 Billion USD | 0.74% |
| 2008 | 1.02 Billion USD | 11.0% |
| 2007 | 922.55 Million USD | 24.82% |
| 2006 | 739.11 Million USD | 15.83% |
| 2005 | 638.09 Million USD | 16.19% |
| 2004 | 549.18 Million USD | 15.38% |
| 2003 | 475.99 Million USD | 15.34% |
| 2002 | 412.67 Million USD | 6.89% |
| 2001 | 386.08 Million USD | 5.08% |
| 2000 | 367.43 Million USD | 3.15% |
| 1999 | 356.2 Million USD | 11.35% |
| 1998 | 319.9 Million USD | 21.63% |
| 1997 | 263 Million USD | -1.76% |
| 1996 | 267.7 Million USD | 41.94% |
| 1995 | 188.6 Million USD | 49.21% |
| 1994 | 126.4 Million USD | 35.77% |
| 1993 | 93.1 Million USD | 61.35% |
| 1992 | 57.7 Million USD | 89.18% |
| 1991 | 30.5 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 964.09 Million USD | 6.93% |
| 2024 Q2 | 1 Billion USD | 4.1% |
| 2024 Q3 | 975.54 Million USD | -2.79% |
| 2023 Q3 | 915.52 Million USD | -2.98% |
| 2023 Q2 | 943.63 Million USD | 4.83% |
| 2023 Q1 | 900.19 Million USD | 8.64% |
| 2023 FY | 3.66 Billion USD | 8.72% |
| 2023 Q4 | 901.6 Million USD | -1.52% |
| 2022 Q3 | 841.66 Million USD | -2.19% |
| 2022 Q1 | 836.54 Million USD | 4.43% |
| 2022 Q2 | 860.54 Million USD | 2.87% |
| 2022 FY | 3.36 Billion USD | 4.73% |
| 2022 Q4 | 828.56 Million USD | -1.56% |
| 2021 Q4 | 801.09 Million USD | -1.15% |
| 2021 Q1 | 777.7 Million USD | 7.87% |
| 2021 Q2 | 826.14 Million USD | 6.23% |
| 2021 Q3 | 810.42 Million USD | -1.9% |
| 2021 FY | 3.21 Billion USD | 18.79% |
| 2020 Q4 | 720.93 Million USD | -0.12% |
| 2020 Q1 | 626.33 Million USD | 3.45% |
| 2020 FY | 2.7 Billion USD | 12.45% |
| 2020 Q2 | 637.59 Million USD | 1.8% |
| 2020 Q3 | 721.78 Million USD | 13.21% |
| 2019 Q1 | 576.05 Million USD | 4.85% |
| 2019 FY | 2.4 Billion USD | 8.75% |
| 2019 Q4 | 605.44 Million USD | 0.02% |
| 2019 Q3 | 605.3 Million USD | -2.39% |
| 2019 Q2 | 620.1 Million USD | 7.65% |
| 2018 Q4 | 549.38 Million USD | 0.72% |
| 2018 FY | 2.21 Billion USD | 12.4% |
| 2018 Q2 | 580.75 Million USD | 8.02% |
| 2018 Q1 | 537.65 Million USD | 6.23% |
| 2018 Q3 | 545.44 Million USD | -6.08% |
| 2017 Q1 | 462.02 Million USD | 4.29% |
| 2017 FY | 1.96 Billion USD | 10.91% |
| 2017 Q4 | 506.12 Million USD | 2.88% |
| 2017 Q2 | 508.94 Million USD | 10.16% |
| 2017 Q3 | 491.97 Million USD | -3.33% |
| 2016 Q1 | 417.55 Million USD | 4.47% |
| 2016 FY | 1.77 Billion USD | 10.83% |
| 2016 Q4 | 442.99 Million USD | -1.18% |
| 2016 Q3 | 448.3 Million USD | -3.91% |
| 2016 Q2 | 466.56 Million USD | 11.74% |
| 2015 Q3 | 406.38 Million USD | -1.68% |
| 2015 FY | 1.6 Billion USD | 7.81% |
| 2015 Q1 | 382.47 Million USD | 8.67% |
| 2015 Q2 | 413.34 Million USD | 8.07% |
| 2015 Q4 | 399.68 Million USD | -1.65% |
| 2014 Q3 | 383.52 Million USD | -1.69% |
| 2014 Q1 | 360.2 Million USD | 1.73% |
| 2014 FY | 1.48 Billion USD | 7.9% |
| 2014 Q2 | 390.12 Million USD | 8.31% |
| 2014 Q4 | 351.95 Million USD | -8.23% |
| 2013 Q1 | 332.1 Million USD | 3.93% |
| 2013 FY | 1.37 Billion USD | 6.47% |
| 2013 Q4 | 354.07 Million USD | 4.66% |
| 2013 Q3 | 338.29 Million USD | -4.05% |
| 2013 Q2 | 352.58 Million USD | 6.17% |
| 2012 Q3 | 315.47 Million USD | -6.01% |
| 2012 Q2 | 335.64 Million USD | 4.02% |
| 2012 Q1 | 322.67 Million USD | 5.04% |
| 2012 FY | 1.29 Billion USD | 6.13% |
| 2012 Q4 | 319.53 Million USD | 1.29% |
| 2011 Q4 | 307.2 Million USD | 2.08% |
| 2011 FY | 1.21 Billion USD | 10.45% |
| 2011 Q1 | 292.67 Million USD | 3.14% |
| 2011 Q2 | 317.86 Million USD | 8.61% |
| 2011 Q3 | 300.95 Million USD | -5.32% |
| 2010 FY | 1.1 Billion USD | 6.96% |
| 2010 Q4 | 283.75 Million USD | 5.24% |
| 2010 Q3 | 269.62 Million USD | -4.21% |
| 2010 Q2 | 281.48 Million USD | 4.83% |
| 2010 Q1 | 268.52 Million USD | -0.67% |
| 2009 FY | 1.03 Billion USD | 0.74% |
| 2009 Q3 | 259.12 Million USD | -2.48% |
| 2009 Q2 | 265.72 Million USD | 12.38% |
| 2009 Q1 | 236.45 Million USD | -2.81% |
| 2009 Q4 | 270.33 Million USD | 4.33% |
| 2008 FY | 1.02 Billion USD | 11.0% |
| 2008 Q3 | 251.09 Million USD | -10.51% |
| 2008 Q2 | 280.57 Million USD | 12.65% |
| 2008 Q4 | 243.29 Million USD | -3.11% |
| 2008 Q1 | 249.07 Million USD | 1.68% |
| 2007 Q3 | 229.38 Million USD | -3.23% |
| 2007 Q2 | 237.04 Million USD | 12.26% |
| 2007 Q1 | 211.15 Million USD | 9.86% |
| 2007 FY | 922.55 Million USD | 24.82% |
| 2007 Q4 | 244.96 Million USD | 6.79% |
| 2006 FY | 739.11 Million USD | 15.83% |
| 2006 Q4 | 192.2 Million USD | 2.58% |
| 2006 Q3 | 187.38 Million USD | -2.08% |
| 2006 Q2 | 191.36 Million USD | 13.8% |
| 2006 Q1 | 168.16 Million USD | 0.72% |
| 2005 Q1 | 152.42 Million USD | 5.65% |
| 2005 FY | 638.09 Million USD | 16.19% |
| 2005 Q4 | 166.97 Million USD | 5.63% |
| 2005 Q3 | 158.06 Million USD | -1.59% |
| 2005 Q2 | 160.63 Million USD | 5.38% |
| 2004 Q2 | 137.37 Million USD | 2.97% |
| 2004 Q3 | 134.11 Million USD | -2.38% |
| 2004 Q4 | 144.27 Million USD | 7.58% |
| 2004 FY | 549.18 Million USD | 15.38% |
| 2004 Q1 | 133.41 Million USD | 6.87% |
| 2003 Q2 | 121.84 Million USD | 11.53% |
| 2003 Q1 | 109.24 Million USD | 3.17% |
| 2003 Q3 | 120.06 Million USD | -1.46% |
| 2003 Q4 | 124.83 Million USD | 3.98% |
| 2003 FY | 475.99 Million USD | 15.34% |
| 2002 Q4 | 105.89 Million USD | 1.3% |
| 2002 Q3 | 104.53 Million USD | -1.09% |
| 2002 Q2 | 105.69 Million USD | 9.47% |
| 2002 Q1 | 96.55 Million USD | 1.49% |
| 2002 FY | 412.67 Million USD | 6.89% |
| 2001 FY | 386.08 Million USD | 5.08% |
| 2001 Q2 | 102 Million USD | 11.57% |
| 2001 Q3 | 97.52 Million USD | -4.39% |
| 2001 Q4 | 95.13 Million USD | -2.45% |
| 2001 Q1 | 91.42 Million USD | -1.29% |
| 2000 Q2 | 93.55 Million USD | 2.94% |
| 2000 FY | 367.43 Million USD | 3.15% |
| 2000 Q4 | 92.61 Million USD | 2.47% |
| 2000 Q3 | 90.38 Million USD | -3.39% |
| 2000 Q1 | 90.87 Million USD | 2.57% |
| 1999 Q2 | 91.5 Million USD | 2.12% |
| 1999 Q3 | 86.4 Million USD | -5.57% |
| 1999 Q4 | 88.6 Million USD | 2.55% |
| 1999 FY | 356.2 Million USD | 11.35% |
| 1999 Q1 | 89.6 Million USD | 8.34% |
| 1998 Q2 | 80.9 Million USD | 3.98% |
| 1998 Q3 | 78.5 Million USD | -2.97% |
| 1998 Q1 | 77.8 Million USD | 8.36% |
| 1998 FY | 319.9 Million USD | 21.63% |
| 1998 Q4 | 82.7 Million USD | 5.35% |
| 1997 FY | 263 Million USD | -1.76% |
| 1997 Q1 | 60.5 Million USD | -18.9% |
| 1997 Q2 | 58.9 Million USD | -2.64% |
| 1997 Q3 | 71.7 Million USD | 21.73% |
| 1997 Q4 | 71.8 Million USD | 0.14% |
| 1996 FY | 267.7 Million USD | 41.94% |
| 1996 Q2 | 65.9 Million USD | 14.81% |
| 1996 Q1 | 57.4 Million USD | 5.9% |
| 1996 Q4 | 74.6 Million USD | 6.88% |
| 1996 Q3 | 69.8 Million USD | 5.92% |
| 1995 Q3 | 48.7 Million USD | 4.73% |
| 1995 Q4 | 54.2 Million USD | 11.29% |
| 1995 FY | 188.6 Million USD | 49.21% |
| 1995 Q1 | 39.2 Million USD | 8.89% |
| 1995 Q2 | 46.5 Million USD | 18.62% |
| 1994 Q2 | 31.1 Million USD | 13.5% |
| 1994 Q3 | 31.9 Million USD | 2.57% |
| 1994 Q4 | 36 Million USD | 12.85% |
| 1994 FY | 126.4 Million USD | 35.77% |
| 1994 Q1 | 27.4 Million USD | 2.24% |
| 1993 FY | 93.1 Million USD | 61.35% |
| 1993 Q2 | 23.1 Million USD | 18.46% |
| 1993 Q4 | 26.8 Million USD | 12.61% |
| 1993 Q1 | 19.5 Million USD | 18.9% |
| 1993 Q3 | 23.8 Million USD | 3.03% |
| 1992 Q1 | 11.8 Million USD | 26.88% |
| 1992 Q4 | 16.4 Million USD | 11.56% |
| 1992 Q3 | 14.7 Million USD | -0.68% |
| 1992 FY | 57.7 Million USD | 89.18% |
| 1992 Q2 | 14.8 Million USD | 25.42% |
| 1991 Q1 | 6.3 Million USD | 0.0% |
| 1991 FY | 30.5 Million USD | 0.0% |
| 1991 Q3 | 7.5 Million USD | 1.35% |
| 1991 Q2 | 7.4 Million USD | 17.46% |
| 1991 Q4 | 9.3 Million USD | 24.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -11615.424% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -27287.085% |
| Aspira Women's Health Inc. | 9.15 Million USD | -39892.932% |
| Biodesix, Inc. | 49.08 Million USD | -7358.091% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -37368.281% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -144458.912% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -144458.912% |
| Bionano Genomics, Inc. | 36.11 Million USD | -10036.651% |
| CareDx, Inc | 280.32 Million USD | -1205.972% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 219.78 Million USD | -1565.675% |
| DarioHealth Corp. | 20.35 Million USD | -17888.173% |
| Exact Sciences Corporation | 2.49 Billion USD | -46.452% |
| Fulgent Genetics, Inc. | 289.21 Million USD | -1165.833% |
| Guardant Health, Inc. | 563.94 Million USD | -549.165% |
| ICON Public Limited Company | 8.12 Billion USD | 54.915% |
| Illumina, Inc. | 4.5 Billion USD | 18.718% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -117548.157% |
| iSpecimen Inc. | 9.92 Million USD | -36774.347% |
| Standard BioTools Inc. | 106.34 Million USD | -3342.687% |
| MDxHealth SA | 70.19 Million USD | -5115.553% |
| 23andMe Holding Co. | 219.63 Million USD | -1566.812% |
| Medpace Holdings, Inc. | 1.88 Billion USD | -94.128% |
| Myriad Genetics, Inc. | 678.4 Million USD | -439.645% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -408726.226% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| NeoGenomics, Inc. | 591.64 Million USD | -518.777% |
| Neogen Corporation | 924.22 Million USD | -296.112% |
| Inotiv, Inc. | 572.42 Million USD | -539.552% |
| Natera, Inc. | 1.08 Billion USD | -238.172% |
| OpGen, Inc. | 3.41 Million USD | -106998.019% |
| OPKO Health, Inc. | 863.49 Million USD | -323.969% |
| Psychemedics Corporation | 22.09 Million USD | -16466.897% |
| Prenetics Global Limited | 21.74 Million USD | -16737.638% |
| Prenetics Global Limited | 21.74 Million USD | -16737.638% |
| Precipio, Inc. | 15.19 Million USD | -23989.972% |
| Personalis, Inc. | 73.48 Million USD | -4882.176% |
| RadNet, Inc. | 1.61 Billion USD | -126.456% |
| Sera Prognostics, Inc. | 306 Thousand USD | -1196289.869% |
| Sotera Health Company | 1.04 Billion USD | -248.899% |
| Neuronetics, Inc. | 71.34 Million USD | -5031.122% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -7895.966% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -7895.966% |
| Trinity Biotech plc | 56.83 Million USD | -6341.711% |
| T2 Biosystems, Inc. | 7.19 Million USD | -50796.052% |
| Twist Bioscience Corporation | 312.97 Million USD | -1069.731% |
| Exagen Inc. | 52.54 Million USD | -6866.874% |